Saturday, August 29


Global private equity firm LeapFrog Investments plans to invest $80 million to $100 million in India’s healthcare sector over the next two years, a top executive told Reuters, as it seeks to benefit from the rising demand for medical services.

Expanding insurance coverage and greater use of diagnostics and preventive care in a ‌country with ⁠high rates ⁠of chronic disease have boosted healthcare spending. India’s healthcare sector was valued at about $180 ​billion in 2023 and is expected to grow to $320 billion by 2028, government data ​showed.

The healthcare and pharmaceutical sector recorded 594 M&A and private equity deals worth over $30 billion between 2022 and 2024, according to data from advisory ​firm Grant Thornton Bharat and the Association of ⁠Healthcare Providers ‌India.

KKR’s deal to acquire Medicover Hospital’s India ​business for 1.2 ​billion euros ($1.4 billion) is among the latest deals.

London-based LeapFrog ⁠is evaluating an investment in an asset-light, single-specialty healthcare ​provider, Biju Mohandas, the firm’s global head and partner ​for healthcare, told Reuters earlier this month, declining to provide details.

It is evaluating investing in hospitals, particularly those serving patients outside major cities, as well as specialty-care providers focused on maternal and child health, ophthalmology and oncology.

“Our investment thesis is centred on two realities – growing insurance penetration ‌and significant disposable income with the ability to afford quality healthcare,” Mohandas said.

LeapFrog’s existing Indian investments include diagnostics provider ​Redcliffe Labs and ​digital health platform ⁠Healthify.

The firm is also exploring opportunities in India’s pharmaceutical and medical equipment sectors, Mohandas said.

LeapFrog is investing from an $808 million fund and related co-investment ​vehicles, giving it more than $1 billion to deploy across Asia and Africa.

“We have already deployed a significant portion of the capital, including recent investments in the Philippines and Vietnam, but we see substantial deployment opportunities in India over the next couple of years,” Mohandas said. ($1 = 0.8589 euros)

  • Published On Aug 29, 2026 at 12:02 AM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETHealthworld industry right on your smartphone!




Source link

Share.
Leave A Reply

Exit mobile version